Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Study looks at nicotine gum, smoking cessation

This article was originally published in The Tan Sheet

Executive Summary

Smokers who began nicotine gum treatment four weeks prior to a target date to quit smoking were no less likely to stop smoking or experience withdrawal symptoms than subjects who started using the gum on their quit date, according to a Swiss study. Researchers led by Jean-Francois Etter, of the University of Geneva's Institute of Social and Preventive Medicine, hypothesized that pre-cessation treatment with gum would be more effective than post-cessation treatment because they "thought that obtaining nicotine from gum instead of cigarettes would weaken cigarette reinforcement." The researchers write in a report published June 8 in the Archives of Internal Medicine that the 314 daily smokers studied might have had better success with additional face-to-face counseling or with a nicotine patch, which maintains a steady level of the drug in the bloodstream. Although the study results dispute the status of nicotine gum as a "cut down to quit" product in many countries, the researchers say there remains "a need to explore strategies to increase the reach and efficacy" of nicotine replacement therapies

You may also be interested in...



Allegations Of EU Notified Body Fees Having Escalated And Of Being Unpredictable

US medtech companies are worried EU notified bodies have too much freedom over setting their fees, accusing them of lacking transparency and being inconsistent with what they charge. They also allege that notified body practices mean some products will miss the four-year grace period.


Sales Already Growing As Vascepa Secures Cardio Approval

MTI Outlook 2020: Medtechs Enter The Decade Of Digital, Consumers and Wellness

For health-care providers and medtech manufacturers alike, the decade ahead will require a coming to terms with digital technologies and integrating new methods of payment. Quality of service delivery remains the market-entry criterion, but companies will have to adapt to evolving health-care models. The stakes are high. Will manufacturers be able to capitalize on the changes in a market that is more competitive and unpredictable than ever?

Topics

UsernamePublicRestriction

Register

PS103024

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel